Clofibrate + DantroleneModerate
Clofibrate reduces binding of dantrolene to plasma proteins, potentially increasing free drug concentration.
Source: NLP:dantrolene
Clofibrate Interactions
8 interactions on record
May increase serum thyroxine-binding globulin concentration, resulting in initial transient increase in FT4 followed by decreased serum T4.
Source: NLP:levothyroxine sodium
Clofibrate + Liothyronine SodiumModerate
May increase serum thyroxine-binding globulin concentration, altering T3 serum transport without affecting free thyroxine concentration. Closely monitor thyroid hormone parameters.
Source: NLP:liothyronine sodium
CHCs have been shown to decrease plasma concentrations of clofibric acid.
Source: NLP:norelgestromin and ethinyl estradiol
Oral contraceptives may induce conjugation of clofibric acid, increasing its clearance.
Source: NLP:norethindrone acetate and ethinyl estradiol and ferrous fumarate
Oral contraceptives may induce conjugation of clofibric acid, increasing its clearance and decreasing plasma concentrations.
Source: NLP:norethindrone acetate and ethinyl estradiol
Clofibrate + UrsodiolModerate
Increases hepatic cholesterol secretion and may counteract the effectiveness of ursodiol.
Source: NLP:ursodiol
Clofibrate + UsodiolModerate
Lipid-lowering drug that increases hepatic cholesterol secretion and encourages cholesterol gallstone formation, counteracting ursodiol effectiveness.
Source: NLP:usodiol